QIM
TGTX icon

Quantitative Investment Management’s TG Therapeutics TGTX Stock Holding History

Quantitative Investment Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,987
Closed -$711K – 438
2024
Q2 		$711K Buy
+39,987
New +$638K 0.08% 195
2023
Q3 		– Sell
-24,351
Closed -$604K – 327
2023
Q2 		$604K Buy
+24,351
New +$629K 0.06% 214
2021
Q2 		– Sell
-22,030
Closed -$1.06M – 588
2021
Q1 		$1.06M Sell
22,030
-41,206
-65% -$1.98M 0.09% 221
2020
Q4 		$3.29M Buy
+63,236
New +$2.14M 0.27% 89
2018
Q3 		– Sell
-148,100
Closed -$1.95M – 867
2018
Q2 		$1.95M Buy
148,100
+32,500
+28% +$447K 0.04% 366
2018
Q1 		$1.64M Buy
+115,600
New +$1.48M 0.03% 494

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantitative Investment Management's TGTX Position: Q3 2024 in Review

Quantitative Investment Management sold out of TG Therapeutics (TGTX) in Q3 2024, closing a stake of 39,987 shares — an estimated $711K sold.

Quantitative Investment Management first reported a position in TGTX in Q1 2018 and held it in 6 quarters. The position peaked at $3.29M in Q4 2020. 308 funds tracked by Wall St. Rank hold TGTX as of Q3 2024.

  • Quantitative Investment Management reported no remaining TG Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Quantitative Investment Management sold 39,987 TG Therapeutics shares in Q3 2024, an estimated $711K.
  • Quantitative Investment Management first reported a position in TG Therapeutics in Q1 2018 and held it in 6 quarters.
  • Quantitative Investment Management's TG Therapeutics position peaked at $3.29M in Q4 2020.
  • 308 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2024.

Based on Quantitative Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.